![]() | |
Clinical data | |
---|---|
Other names | CI-1041 |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C21H23FN2O3S |
Molar mass | 402.48 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Besonprodil (CI-1041) is a drug which acts as an NMDA antagonist, selective for the NR2B subunit.[1][2] It is under development as a supplemental medication for Parkinson's disease, and has been shown in animals to be effective in counteracting the dyskinesias associated with long-term treatment with levodopa and related drugs.[3][4][5][6][7]
![]() | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |